Tacrolimus concentrations in blood during topical treatment of atopic dermatitis [4]

Lancet

Volumn 348, Issue 9036, 1996, Pages 1240-1241

  Kawashima, M ^a   Nakagawa, H ^a   Ohtsuki, M ^a   Tamaki, K ^a   Ishibashi, Y ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG USE; ERYTHRODERMA; HUMAN; LETTER; MULTICENTER STUDY; NEPHROTOXICITY; OINTMENT; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029846441     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65512-2     Document Type: Letter

References (3)

1. K Abu-Elmagd D Van Thiel BV Jegasothy FK506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc 23 1991 3322 3324
2. H Nakagawa T Etoh Y Ishibashi Tacrolimus ointment for atopic dermatitis. Lancet 344 1994 883
3. J Hanifin G Rajka Diagnostic features of atopic dermatitis Acta Derm Venereol (Stockh) 92 suppl 1980 42 47